General MedicationsINJECTIONGeneric
SUGAMMADEX
SUGAMMADEX
Standard Dose
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview SUGAMMADEX is listed in Drugs@FDA under application 214319 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SUGAMMADEX Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/2ML (EQ 100MG BASE/ML) Sponsor SUN PHARM INDS Submission history Latest submission status date: 2025-09-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview SUGAMMADEX is listed in Drugs@FDA under application 214319 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SUGAMMADEX Form and strength INJECTABLE;INJECTION - EQ 200MG BASE/2ML (EQ 100MG BASE/ML) Sponsor SUN PHARM INDS Submission history Latest submission status date: 2025-09-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.